Back to Trials
NCT05938543NARecruiting

Cerebellar TMS and Satiety in Prader-Willi Syndrome

Brigham and Women's Hospital

Start Date

9/1/2023

Completion Date

10/1/2026

Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study hyperphagia and satiety in Prader-Willi syndrome. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about how TMS might improve hyperphagia in Prader-Willi syndrome.

Eligibility Criteria

Age Range: 18 years to 64 years

Inclusion Criteria: * Diagnosis of Prader-Willi syndrome Exclusion Criteria: * contraindications for TMS or MRI including : * history of neurological disorder * history of head trauma resulting in loss of consciousness * history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy * metal in brain or skull * implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt claustrophobic in MRI

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation (rTMS)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Prader-Willi Syndrome

Locations

McLean Hospital

Belmont, Massachusetts 02478

United States